Clinical Evaluation of Herbal Medicine (ICH-012) in Treating Acute Cerebral Haemorrhage: Safety and Efficacy from 6- to 72-Hour Time Window (CRRICHTrial-II).
Qixin ZhangLiling ZengXiuyan ChenYuexiang ZhouBaoying GongHaijun LiJianwen GuoPublished in: Evidence-based complementary and alternative medicine : eCAM (2018)
A large amount of data from high-quality RCTs is needed for the extensive clinical application of herbal medicine. The CRRICHTrial-II will evaluate the safety and effectiveness of ICH-012 in a safer time window between 6 and 72 h and investigate the possible mechanisms of action and direction of herbal medicine in the haematoma growth after HICH. Trial registration at ClinicalTrial.gov, ID: NCT03354026, is registered on 23rd Nov. 2017.
Keyphrases
- clinical evaluation
- liver failure
- randomized controlled trial
- study protocol
- systematic review
- blood pressure
- clinical trial
- subarachnoid hemorrhage
- respiratory failure
- electronic health record
- phase iii
- phase ii
- drug induced
- hepatitis b virus
- open label
- brain injury
- deep learning
- cerebral ischemia
- cerebral blood flow